Table 1.
Hypoxia and sorafenib resistance in HCC
Cell lines/animal models/human samples | Effects on HIF after sorafenib treatment | Global effects | References |
---|---|---|---|
HCCs from patients HepG2, Huh7, PLC-5, Hep3B, and SK-Hep-1 cells BALB/c mice inoculated with Hep3B or Huh7 and orthotopic Huh7 hepatic tumors |
↑ HIF-1α | ↑ GLUT-1, MDR1, and VEGF Activation of NF-κB | 32 |
Human HCC samples HepG2, SMMC-7721, BEK-7402, Hep3B, and Huh7 cells BALB/c nude mice subcutaneous model with HepG2 cells |
↑ HIF-1α | ↑ GLUT-1, MDR1, and VEGF | 44 |
Sorafenib-resistant Huh7 cells (Huh7R) Tumor xenograft model by subcutaneously injecting Huh7 and Huh7R cells in BALB/c nude mice |
↑ HIF-1α | ↑ Galectin-1 | 45 |
HCC samples HepG2, SMMC-7721, MHCC-LM3, and CSQT-2 cells DEN-induced HCC in C57BL/6 mice Mouse xenograft model derived from SMMC-7721 cells |
↑ HIF-1α | ↑ GLUT-1, HK2, PDK1, LDHA, and VEGF | 46 |
HCC-LM3 and Bel-7402 cells BALB/c nu/nu injected with HCC-LM3 cells |
↑ HIF-1α | ↑ GLUT-1 and HK2 | 47 |
HepG2 and Huh7 cells BALB/c mice with Huh7 subcutaneously injected |
↓ HIF-1α ↑ HIF-2α |
Activation of TGF-α/EGFR | 26 |
HepG2 and Huh7 cells BALB/c mice with Huh7 subcutaneously injected |
↓ HIF-1α ↑ HIF-2α |
↑ VEGF and cyclin D1 ↓ LDHA |
25 |
HepG2, Huh7, and SK-Hep-1 cells Mice HCC nodules Orthotopic HCC mouse models with SK-Hep-1 cells |
↑ HIF-2α | ↑ AR | 25 |
HepG2, Huh7, Bel-7402, and SMMC-7402 cells BALB/c mice subcutaneously inoculated with HepG2 |
↓ HIF-1α ↑ HIF-2α |
↑ β-catenin/c-Myc/PCNA | 34 |
HCC cells | ↑ HIF-2α | – | 49 |
MHCC97H cells BALB/c mice subcutaneously injected with MHCC97H cells |
↑ HIF-2α | ↓ TIP30 | 50 |
AR androgen receptor, c-Myc Myc proto-oncogene protein, DEN diethylnitrosamine, EGFR epidermal growth factor receptor, GLUT-1 glucose transporter 1, HCC hepatocellular carcinoma, HIF hypoxia-inducible factor, HK2 hexokinase 2, LDHA lactate dehydrogenase A, MDR1 multidrug resistance protein 1, PCNA proliferating cell nuclear antigen, PDK1 pyruvate dehydrogenase kinase isoform 1, TGF-α transforming growth factor α, TIP30 oxidoreductase HTATIP2, VEGF vascular endothelial growth factor